Key facts
- It has raised $1.6M across 1 recorded rounds; the latest was Seed Round ($3.0M) in Apr 2026.
- Notable investors include US National Science Foundation, VentureWell, Ohio Department of Development, Bounce Innovation Hub, Burton D. Morgan Foundation — 7 tracked in total.
- Auxilium Health has filed 1 Form D with the SEC, most recently May 2026 ($3.0M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Auxilium Health
Funding rounds
1 roundsAbout Auxilium Health
Operator of a biotechnology research company intended to develop wound care technology. The company develops biomaterials for skin tissue infection and regeneration and hard-to-heal wounds that accelerate healing and monitor infections and reduce the time and cost spent on medical intervention, enabling patients to be rescued from diseases.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2022
- Employees
- 6
- Website
- auxiliumhealth.xyz/
- Ownership
- Privately Held (backing)
Auxilium Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Auxilium Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Auxilium Health in its N-PORT filings yet. We sweep new filings monthly.